Streetbeat News

Stock Prices

AMD

AMD shares are trading lower following a recent gain, which was in sympathy with NVIDIA's performance.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 7:53 pm

OCEA

Ocean Biomedical's shares resumed trading and were then halted again due to a circuit breaker triggered by a significant upside, with the stock now up 156.6%.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 7:52 pm

MATIC

USDC

Crypto bettors on Polymarket are heavily favoring Donald Trump to win every state in the GOP primaries against Nikki Haley, with an 87% chance of Trump winning every state. Trump's lead in early voting states and a recent Morning Consult poll showing a 63-point lead over Haley among Republican voters underscore his dominance. The betting market's odds have increased from 50% in January to 87% currently. Bettors also predict a high chance of Trump winning by at least 20% in the upcoming South Carolina primary, a key state for Haley.

Portfolio Pulse from Chris Katje

February 23, 2024 | 7:48 pm

ZS

Recent options trading trends indicate a bearish sentiment towards Zscaler (NASDAQ:ZS) among deep-pocketed investors, with a notable division in sentiment (36% bullish, 63% bearish). The trading activity suggests a price target range of $110 to $300 for ZS in the next three months. Zscaler, a SaaS firm specializing in cybersecurity, has seen its stock price increase by 1.67% to $229.93. Analyst opinions on ZS vary, with an average price target of $244.8, though ratings range from Overweight to Neutral.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 7:46 pm

ALB

Financial analysts have observed a bullish trend in the options market for Albemarle (NYSE:ALB), with 70% of traders showing bullish sentiment. The analysis of unusual trades revealed a preference for calls over puts, indicating a predicted price range for ALB between $90.0 and $230.0. Albemarle, a leading lithium producer for batteries, especially in electric vehicles, has seen its stock price increase by 0.85% to $119.19. Analyst ratings over the past month suggest an average target price of $140.6, with varying recommendations from Overweight to Neutral.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 7:45 pm

OCEA

Ocean Biomedical's shares were halted due to a circuit breaker triggered by a significant upside movement, with the stock now showing an increase of 105.7%.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 7:43 pm

DIS

FOXA

WBD

Citigroup analyst Jason Bazinet upgraded Fox Corp (NASDAQ:FOXA) from Neutral to Buy, raising the price target from $34 to $35, following the announcement of a sports joint venture with Walt Disney Co (NYSE:DIS) and Warner Bros Discovery, Inc (NASDAQ:WBD). The JV, which encompasses ~50% of US sports rights, is expected to positively impact Fox's revenue and EBITDA for fiscal years 2025 and 2026. The Justice Department is reviewing the JV due to potential consumer and market concerns. Fox's Q2 2023 revenues were $4.23 billion, with an adjusted EPS of $0.34, beating consensus.

Portfolio Pulse from Anusuya Lahiri

February 23, 2024 | 7:42 pm

NICE

NICE Ltd (NASDAQ:NICE) reported strong Q4 fiscal 2023 results with a 9.6% year-over-year revenue growth to $623.19 million, surpassing consensus estimates. Adjusted EPS rose to $2.36 from $2.04, beating expectations. The company provided optimistic FY24 guidance, expecting significant revenue and EPS growth. Following the report, analysts from Wedbush, RBC Capital, and JMP Securities raised their price targets on NICE. Despite the positive results and outlook, NICE shares fell 2.7% to $238.90.

Portfolio Pulse from Avi Kapoor

February 23, 2024 | 7:39 pm

ARM

Arm Holdings shares are trading higher amid continued volatility in semiconductor stocks.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 7:34 pm

EVH

Evolent Health, Inc. (NYSE:EVH) reported Q4 earnings of 23 cents per share, surpassing estimates of 15 cents. Sales were $556.05 million, exceeding expectations of $542.39 million. CEO Seth Blackley highlighted a strong year with over 45% annual revenue growth and successful integration of NIA. Shares rose 11.5% to $33.20. Canaccord Genuity and JMP Securities adjusted their price targets on EVH following the results.

Portfolio Pulse from Avi Kapoor

February 23, 2024 | 7:31 pm